QUEBEC, Jan. 9 /CNW Telbec/ - Victhom Human Bionics Inc., "Victhom" (TSX:
VHB), today announced the unveiling of its updated corporate Website at
www.victhom.com. The Website features a new structure that highlights advances
in the Company's two operating divisions; Neurobionix, which is developing an
implantable neurostimulation device for gait disorders, and Biotronix, which
is developing and manufacturing computerized prostheses for above-knee
Commenting on the new Website, Normand Rivard, Acting President and Chief
Financial Officer, stated: "The new layout provides users with more intuitive
navigation, enhanced visual content and a comprehensive view of the Company's
technologies and products". He went on to say, "This redesigned Website
affirms our commitment to provide relevant information and educate all of our
stakeholders including patients, medical professionals, investors, and current
and future business partners".
The Neurobionix division portion of the Website includes a new "Patient
section" that provides information on the impact of cerebral stroke and a
particular aspect of gait disorder known as foot drop. This section presents
contemporary treatment options for foot drop sufferers as well as the emerging
use of neurostimulation devices that provide instantaneous assistance to
A new "Medical Professional section" has been added and designed for use
by members of the professional medical community. This section provides
medical and technical information on the Company's proprietary implantable
assistive device known as Neurostep(R), which is currently in clinical trials
and designed to restore mobility to persons suffering from foot drop.
Information about the product includes a new animation video demonstrating
various aspects of the Neurostep(R) System as well as updates regarding the
Company's clinical activities.
The Biotronix division section highlights the Company's biomechatronic
technology capabilities and specifically the Power Knee, a motorized
battery-powered transfemoral prosthesis for above-knee amputees exclusively
distributed by our business partner Ossur hf (www.ossur.com).
Victhom discovers, develops and manufactures bionic devices involved in
the treatment of a variety of physical and physiological dysfunctions.
Victhom's Neurobionix division focuses on the development and
commercialization of technologies and products involving implantable devices
that feature neurosensing and neurostimulation components, integrated with
artificial intelligence. Victhom's Biotronix division develops biomechatronic
products to support or replace peripheral limbs in what is known as the
orthotics and prosthetics market.
Some of the statements made herein may constitute forward-looking
statements. These statements relate to future events or our future financial
performance and involve known and unknown risks, uncertainties and other
factors that may cause Victhom's actual results, performance or achievements
to be materially different from those expressed or implied by any of Victhom's
statements. Actual events or results may differ materially. We disclaim any
intention, and assume no obligation, to update these forward-looking
For further information:
For further information: Normand Rivard, Acting President & CFO, Victhom
Human Bionics Inc., (418) 872-5665, Fax: (418) 872-6926,
firstname.lastname@example.org, www.victhom.com; Source: Victhom Human Bionics